Description

5-(tert-Butyloxycarbonyamino)Methyl-3-Pyridin-3-Yl-[1,2,4]Oxadiazole is a high-purity, heterocyclic organic compound featuring a pyridine-linked [1,2,4]oxadiazole core protected by a Boc (tert-butoxycarbonyl) group. This compound is a critical pharmaceutical intermediate and building block in medicinal chemistry, valued for its role in constructing complex molecules with potential biological activity. It is primarily sought by R&D and production teams in the pharmaceutical, agrochemical, and advanced material sectors for the synthesis of novel drug candidates and specialty chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of active pharmaceutical ingredients (APIs), particularly for candidates targeting neurological disorders and metabolic diseases.
• Medicinal Chemistry Building Block: Used in high-throughput screening and combinatorial chemistry to create libraries of compounds for drug discovery programs.
• Agrochemical Research: Serves as a synthetic intermediate in the development of new herbicides, fungicides, and insecticides with novel modes of action.
• Chemical Biology Probe Development: Utilized in the design and synthesis of molecular probes for studying enzyme function and biological pathways.
• Material Science: Potential monomer or additive in the synthesis of specialty polymers and advanced organic electronic materials.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting outsourced drug discovery and custom synthesis projects.

Basic Information

Product Name	5-(tert-Butyloxycarbonyamino)Methyl-3-Pyridin-3-Yl-[1,2,4]Oxadiazole
CAS No.	1053656-62-4
Molecular Formula	C14H18N4O3
Molecular Weight	290.32 g/mol
Synonyms	5-((tert-Butoxycarbonylamino)methyl)-3-(pyridin-3-yl)-1,2,4-oxadiazole; 3-Pyridinyl-5-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-1,2,4-oxadiazole; 5-(Boc-aminomethyl)-3-(3-pyridyl)-1,2,4-oxadiazole; tert-Butyl N-[[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl]carbamate; Boc-AM-PyOx; CAS 1053656-62-4; 1,2,4-Oxadiazole, 5-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-(3-pyridinyl)-
EINECS	Contact for details

Quality Control

Our production of 5-(tert-Butyloxycarbonyamino)Methyl-3-Pyridin-3-Yl-[1,2,4]Oxadiazole adheres to stringent quality protocols to ensure batch-to-batch consistency and reliability for critical research and synthesis. Each lot undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting specifications for purity, related substances, and residual solvents. We support compliance with cGMP and ISO 9001 standards for pharmaceutical-grade intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); the container must be kept tightly sealed and under an inert atmosphere (e.g., nitrogen or argon) for long-term storage to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.